Ipsen: Liver Cirrhosis, Biliary trials

The registry lists 10 Liver Cirrhosis, Biliary studies with Ipsen as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 1 2Phase 3 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting ElafibranorNot yet recruitingNCT07906639
• Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During PregnancyRecruitingNCT07556913
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisRecruitingNCT06016842Phase 3
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)Active, not recruitingNCT04526665Phase 3Results posted
• A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)CompletedNCT07049887
• A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)Active, not recruitingNCT06730061Phase 3
• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentActive, not recruitingNCT06447168
• A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.CompletedNCT06383403Phase 3
• An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy SubjectsCompletedNCT03082937Phase 1
• A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedNCT02963077Phase 1